These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 15356942
41. [Factors of cardiovascular risk for hypertensive patients followed during primary care]. Ben Abdelaziz A, Elrafei W, Gaha K, Mandhouj O, Ben Othman A, Ghannem H. Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724 [Abstract] [Full Text] [Related]
42. A second vaccine revolution for the new epidemics of the 21st century. Dyer MR, Renner WA, Bachmann MF. Drug Discov Today; 2006 Nov; 11(21-22):1028-33. PubMed ID: 17055413 [Abstract] [Full Text] [Related]
44. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Gholizadeh L, Davidson P. Health Care Women Int; 2008 Jan; 29(1):3-22. PubMed ID: 18176877 [Abstract] [Full Text] [Related]
45. Cardiovascular disease and the UN millennium development goals: a serious concern. Fuster V. Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):401. PubMed ID: 16874332 [No Abstract] [Full Text] [Related]
46. Cardiovascular morbidity and mortality of the metabolic syndrome. Obunai K, Jani S, Dangas GD. Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915 [Abstract] [Full Text] [Related]
47. Primary prevention of cardiovascular disease in people with dysglycemia. Bianchi C, Miccoli R, Penno G, Del Prato S. Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487 [Abstract] [Full Text] [Related]
48. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ, International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004. Kidney Int Suppl; 2005 Sep; (98):S1-6. PubMed ID: 16108963 [Abstract] [Full Text] [Related]
49. The heart of the matter: reducing CVD risk. Hayman LL, Kamau MW, Stuart-Shor EM. Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396 [No Abstract] [Full Text] [Related]
50. The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk. Bresalier RS, Friedewald VE, Rakel RE, Roberts WC, Williams GW. Am J Cardiol; 2005 Dec 01; 96(11):1589-604. PubMed ID: 16310447 [No Abstract] [Full Text] [Related]
51. Global burden of cardiovascular disease. Sanderson JE, Mayosi B, Yusuf S, Reddy S, Hu S, Chen Z, Timmis A. Heart; 2007 Oct 01; 93(10):1175. PubMed ID: 17890692 [No Abstract] [Full Text] [Related]
52. Both acute and chronic cardiovascular conditions show seasonality: the need of looking beyond conventional risk factors. Turin TC, Rumana N, Kita Y, Nakamura Y, Ueshima H. Aust N Z J Public Health; 2008 Dec 01; 32(6):581-2. PubMed ID: 19076757 [No Abstract] [Full Text] [Related]
53. [The pandemic of cardiovascular diseases, available resources and international cooperation]. Guglielmucci G, Stranges S, Cascone E, Postiglione A, Farinaro E. Ann Ig; 2000 Dec 01; 12(1 Suppl 1):25-30. PubMed ID: 10900750 [No Abstract] [Full Text] [Related]
55. [Analysis of the control status of cardiovascular diseases in the GDR]. Heine H, Anders G, Schmidt H. Dtsch Gesundheitsw; 1971 Dec 02; 26(49):2297-301. PubMed ID: 5148654 [No Abstract] [Full Text] [Related]
56. [Findings and considerations on cardiovascular disease control in Friuli]. Feruglio GA, Passerelli A. Boll Soc Ital Cardiol; 1968 Dec 02; 13(4):465-72. PubMed ID: 5733164 [No Abstract] [Full Text] [Related]
57. Cardiovascular disease in the developing world and its cost-effective management. Gaziano TA. Circulation; 2005 Dec 06; 112(23):3547-53. PubMed ID: 16330695 [No Abstract] [Full Text] [Related]